Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia

Background. Some patients are not prescribed atazanavir because of concern about possible jaundice. Atazanavir-associated hyperbilirubinemia correlates with UGT1A1 rs887829 genotype. We examined bilirubin-related discontinuation of atazanavir in participants from AIDS Clinical Trials Group Study A52...

Descripción completa

Detalles Bibliográficos
Autores principales: Vardhanabhuti, Saran, Ribaudo, Heather J., Landovitz, Raphael J., Ofotokun, Ighovwerha, Lennox, Jeffrey L., Currier, Judith S., Olson, Lana M., Haas, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498287/
https://www.ncbi.nlm.nih.gov/pubmed/26180834
http://dx.doi.org/10.1093/ofid/ofv085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498287/
https://www.ncbi.nlm.nih.gov/pubmed/26180834
http://dx.doi.org/10.1093/ofid/ofv085

Ejemplares similares